<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a woman who, at the age of 27, developed a cerebral <z:mp ids='MP_0006134'>arterial occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The laboratory investigations showed an anti-human beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibody, but no other biological sign of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome or <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient otherwise presented with <z:mp ids='MP_0002055'>diabetes</z:mp> and moderate <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The species specificity of anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies probably explains the discrepancy between false negative results for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> assayed by clotting and ELISA studies and positivity for anti-human beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I </plain></SENT>
<SENT sid="4" pm="."><plain>Further studies will be important to evaluate the frequency of such antibodies, as well as their value as a risk factor for venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, and their signification within the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
</text></document>